Notices. Final rule
415 words·~2 min read·
/register/2016/01/21/2016-01100A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4910-13-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Parts 510 and 516 [Docket No. FDA-2015-N-0002] Conditional Approval of a New Animal Drug No Longer in Effect; Masitinib AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration
(FDA)is amending the animal drug regulations to reflect that the conditional approval of an application for masitinib mesylate tablets, a new animal drug for a minor use, is no longer in effect. DATES: This rule is effective January 21, 2016. FOR FURTHER INFORMATION CONTACT: George K. Haibel, Center for Veterinary Medicine (HFV-6), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-5689, *george.haibel@fda.hhs.gov* . SUPPLEMENTARY INFORMATION: FDA is amending the animal drug regulations to reflect that application 141-308 for conditional approval of KINAVET-CA1 (masitinib mesylate) Tablets, a new animal drug for a minor use sponsored by AB Science, 3 Avenue George V, 75008 Paris, France, is no longer in effect. Elsewhere in this issue of the **Federal Register,** FDA gave notice that conditional approval of this drug, by operation of law, was no longer in effect as of December 15, 2015. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects 21 CFR Part 510 Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements. 21 CFR Part 516 Administrative practice and procedure, Animal drugs, Confidential business information, Reporting and recordkeeping requirements. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 516 are amended as follows: PART 510—NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 510 continues to read as follows: Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e. § 510.600 [Amended] 2. In § 510.600, in the table in paragraph (c)(1), remove the entry for “AB Science” and in the table in paragraph (c)(2), remove the entry for “052913”. PART 516—NEW ANIMAL DRUGS FOR MINOR USE AND MINOR SPECIES 3. The authority citation for 21 CFR part 516 continues to read as follows: Authority: 21 U.S.C. 360ccc-1, 360ccc-2, 371. § 516.1318 [Removed] 4. Remove § 516.1318. Dated: January 14, 2016. Bernadette Dunham, Director, Center for Veterinary Medicine. [FR Doc. 2016-01100 Filed 1-20-16; 8:45 am]
Connectionstraces to 3
3 references not yet in our index
- 5 USC 801-808
- 21 CFR 510
- 21 CFR 516
Citation graph
cites case law
Notices
Final rule
Cite5 USC 801-808
Cite21 CFR 510
Cite21 CFR 516
Cites 6Cited by 0 across 0 sources